Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Notes Payables: 2020

Historic Notes Payables for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Dec 2020 value amounting to $4.9 million.

  • Rocket Pharmaceuticals' Notes Payables was N/A to $5.1 million in Q2 2021 from the same period last year, while for Jun 2021 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2020, which is N/A change from last year.
  • Rocket Pharmaceuticals' Notes Payables amounted to $4.9 million in FY2020.
  • Over the past 5 years, Rocket Pharmaceuticals' Notes Payables peaked at $4.9 million during FY2020, and registered a low of $4.9 million during FY2020.
  • Moreover, its 1-year median value for Notes Payables was $4.9 million (2020), whereas its average is $4.9 million.